Stakeholders: Lawmakers Should Ask CMS To Withdraw Part B Drug-Pay Demo

By Michelle M. Stein / March 23, 2016 at 8:52 PM
As House lawmakers consider what steps to take regarding CMS' Part B drug-pay demo, more than 300 oncologists, specialty doctors, biotechnology groups and others on Thursday (March 17) urged House and Senate leadership to ask CMS to withdraw its proposed Part B drug-pay demonstration. "A Center for Medicare & Medicaid Innovation (CMMI) initiative that focuses on costs rather than patients and health care quality, implemented based on primary care service areas, rather than the unique challenges of patients, is misguided...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.